Hälsa & åldrande

A new study shows that a cancer patient's muscle and fat distribution significantly affects how well checkpoint inhibitor drugs work against advanced lung cancer. The finding could help oncologists predict treatment response before starting expensive therapy, potentially improving outcomes while reducing costs for health systems and insurers.EN

Researchers have identified which famous faces work best for testing memory and cognitive decline in elderly Dutch patients. The findings could improve diagnostic accuracy for dementia screening and help clinicians detect cognitive problems earlier, potentially affecting how hospitals and primary care systems assess aging populations.EN

Researchers are testing whether customized exergames—video games combined with physical movement—can improve memory and thinking skills in older adults experiencing early cognitive decline. If proven effective, the approach could offer a low-cost, engaging alternative to traditional interventions, opening a new market for healthcare providers and tech companies targeting the aging population.EN

Researchers have identified the mechanism by which head and neck cancers trigger muscle wasting—a debilitating side effect that weakens patients and complicates treatment. The finding opens new avenues for therapies that could preserve muscle mass, potentially improving survival rates and quality of life for cancer patients undergoing aggressive treatment.EN

Researchers have identified early- and late-onset subtypes of Alzheimer's disease using validated biological markers, offering a potential roadmap for more targeted treatment development. The finding could reshape how drugmakers design clinical trials and how clinicians identify patients most likely to benefit from emerging therapies.EN

Researchers tested three different approaches to categorize patients with subtle memory loss and mild cognitive impairment, drawing on data from multiple clinics. The findings could help standardize how doctors identify and track cognitive deterioration, potentially improving clinical trial design and treatment targeting for age-related brain diseases.EN

Researchers analyzing Swedish population data found that breast cancer survivors face elevated frailty risk in later life, a finding with implications for long-term care planning and survivorship programs. The discovery suggests healthcare systems and insurers need to better account for physical decline among this growing population group.EN

Researchers have identified how plasma biomarkers for Alzheimer's disease break down during sample handling, a critical finding for the emerging blood-test diagnostics industry. The results could improve accuracy of early-detection tests that diagnostic companies are racing to commercialize, potentially affecting screening protocols and clinical trial reliability worth billions in market value.EN

A new study identifies how sensory impairment drives cognitive decline: by cutting people off from social engagement and leisure activities. The finding suggests that interventions targeting social connection and active aging could reduce dementia risk in older adults—opening a potential pathway for public health programs and insurers to address cognitive health.EN

Researchers have identified changes in the complement system—a key immune defense network—in patients with Parkinson's disease and progressive supranuclear palsy. The discovery could enable earlier diagnosis and point toward new treatment targets for neurodegenerative conditions that affect millions globally and impose enormous healthcare costs.EN

A decade-long study of 45-to-74-year-olds found that people with sluggish insulin responses to glucose were significantly more likely to develop memory problems later. The finding connects metabolic dysfunction to cognitive decline and could prompt employers and healthcare systems to screen for early insulin resistance as a preventive measure.EN

A new study identifies choroid plexus enlargement as a potential early warning sign for cognitive decline, with women and those carrying a specific Alzheimer's gene variant at highest risk. The findings could reshape how doctors screen for dementia risk before symptoms appear, opening new avenues for preventive treatment.EN

Researchers have established baseline standards for a new cognitive screening tool designed to detect early signs of cognitive impairment in the general population. The findings could help doctors identify at-risk patients sooner, potentially opening doors for earlier interventions in neurodegenerative diseases like Alzheimer's.EN

Researchers have developed a practical screening tool that enables primary care doctors to identify frail older patients early, potentially preventing costly hospitalizations and complications. The Primary Care Frailty Index (PC-FI) offers health systems a way to intervene sooner and allocate resources more efficiently to vulnerable seniors.EN

A new study maps how people with Parkinson's disease interact with common digital tools—revealing gaps that could shape product design and healthcare delivery. As the condition affects motor control and cognition, understanding real-world tech barriers has implications for aging populations and adaptive device makers.EN

A new analysis reveals that cost-effectiveness studies of Alzheimer's treatments often fail to account for mortality rates, potentially distorting which therapies appear most valuable. For health systems, insurers, and drugmakers evaluating which treatments to fund or develop, this oversight could lead to poor investment decisions based on incomplete financial projections.EN

A new study of older Canadian adults reveals that public funding has not eliminated disparities in who receives home care services, suggesting that out-of-pocket costs or other barriers remain. For policymakers and healthcare administrators, the finding signals that current funding models may not be delivering equitable access as intended.EN

Researchers discovered that higher education levels protect against memory loss even when brain tissue shrinks with age. The finding suggests cognitive reserve—built through learning—may delay symptoms of Alzheimer's disease, potentially reshaping how clinicians assess dementia risk and design interventions for aging populations.EN

A new analysis examines how GLIM—a global malnutrition screening framework—applies to chronic kidney disease, a condition affecting millions worldwide. The findings could reshape clinical protocols and improve patient outcomes, with implications for healthcare systems managing expensive complications of kidney disease.EN

A sweeping analysis of 21 cohorts across six continents has uncovered significant differences in how men and women develop dementia, suggesting that prevention and treatment strategies may need sex-specific approaches. The finding could reshape clinical practice and pharmaceutical development in a disease affecting millions worldwide.EN

A new study finds that lifelong cognitive engagement—reading, learning, problem-solving—correlates with better memory and thinking skills in older adults, even as their brains show signs of aging. The finding suggests investments in education and mental wellness programs for rural populations could delay cognitive decline and reduce dementia risk.EN

Researchers tracked people whose biological markers suggested they were younger than their chronological age and found the advantage persisted over 20 years. The finding could reshape how companies, insurers, and policymakers think about aging, longevity risk, and what actually predicts healthy aging outcomes.EN

Roflumilast may help patients with mild cognitive impairment preserve brain function, according to new research. The finding could reshape treatment strategy for early dementia stages and create a significant commercial opportunity if cost-effectiveness data supports wider adoption.EN

A Swedish registry study identified widespread prescription risks among elderly patients on multiple drugs using a clinical decision-support tool. The findings highlight gaps in medication safety practices that could drive healthcare costs and adverse events—a growing concern as aging populations take more medications simultaneously.EN

A major analysis reveals that men and women with dementia with Lewy bodies—the second most common dementia type—show distinct patterns of brain degeneration. The finding could reshape how doctors diagnose and treat the disease, potentially allowing for sex-specific therapeutic approaches that improve outcomes.EN